130 related articles for article (PubMed ID: 7801430)
21. Chromosome analysis of canine lymphosarcoma: two cases involving probable centric fusion.
Miles CP; Moldavannu G; Miller DG; Moore A
Am J Vet Res; 1970 Apr; 31(4):783-90. PubMed ID: 5467268
[No Abstract] [Full Text] [Related]
22. Trisomy 1 in a canine mammary tubular adenocarcinoma, complex type.
Mayr B; Eschborn U; Loupal G; Schleger W
Vet Pathol; 1993 May; 30(3):311-3. PubMed ID: 8333114
[No Abstract] [Full Text] [Related]
23. Randomized controlled trial of doxorubicin versus dactinomycin in a multiagent protocol for treatment of dogs with malignant lymphoma.
Khanna C; Lund EM; Redic KA; Hayden DW; Bell FW; Goulland EL; Klausner JS
J Am Vet Med Assoc; 1998 Oct; 213(7):985-90. PubMed ID: 9776993
[TBL] [Abstract][Full Text] [Related]
24. P-glycoprotein expression in canine lymphoma: a relevant, intermediate model of multidrug resistance.
Lee JJ; Hughes CS; Fine RL; Page RL
Cancer; 1996 May; 77(9):1892-8. PubMed ID: 8646690
[TBL] [Abstract][Full Text] [Related]
25. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type.
Ott G; Katzenberger T; Greiner A; Kalla J; Rosenwald A; Heinrich U; Ott MM; Müller-Hermelink HK
Cancer Res; 1997 Sep; 57(18):3944-8. PubMed ID: 9307277
[TBL] [Abstract][Full Text] [Related]
26. Chromosomal aberrations in non-Hodgkin's lymphoma. Biologic and clinical correlations.
Offit K; Chaganti RS
Hematol Oncol Clin North Am; 1991 Oct; 5(5):853-69. PubMed ID: 1938758
[TBL] [Abstract][Full Text] [Related]
27. Chromosomal abnormalities in non-Hodgkin's lymphomas.
Le Beau MM
Semin Oncol; 1990 Feb; 17(1):20-9. PubMed ID: 2406914
[No Abstract] [Full Text] [Related]
28. Evaluation of some prognostic factors for advanced multicentric lymphosarcoma in the dog: 147 cases (1978-1981).
MacEwen EG; Hayes AA; Matus RE; Kurzman I
J Am Vet Med Assoc; 1987 Mar; 190(5):564-8. PubMed ID: 3558097
[TBL] [Abstract][Full Text] [Related]
29. Prognostic implication of cytogenetic findings in 106 patients with non-Hodgkin lymphoma.
Kristoffersson U; Heim S; Mandahl N; Olsson H; Ranstam J; Akerman M; Mitelman F
Cancer Genet Cytogenet; 1987 Mar; 25(1):55-64. PubMed ID: 3467832
[TBL] [Abstract][Full Text] [Related]
30. Chromosome aberrations in canine multicentric lymphomas detected with comparative genomic hybridisation and a panel of single locus probes.
Thomas R; Smith KC; Ostrander EA; Galibert F; Breen M
Br J Cancer; 2003 Oct; 89(8):1530-7. PubMed ID: 14562028
[TBL] [Abstract][Full Text] [Related]
31. Chromosome analyses in dogs.
Reimann-Berg N; Bullerdiek J; Murua Escobar H; Nolte I
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(3):191-6. PubMed ID: 22688796
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations.
Offit K; Wong G; Filippa DA; Tao Y; Chaganti RS
Blood; 1991 Apr; 77(7):1508-15. PubMed ID: 2009370
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic significance of histologic grade, pgp, and p53 expression in canine lymphoma.
Dhaliwal RS; Kitchell BE; Ehrhart E; Valli VE; Dervisis NG
J Am Anim Hosp Assoc; 2013; 49(3):175-84. PubMed ID: 23535752
[TBL] [Abstract][Full Text] [Related]
34. Predictive value of p16 or Rb inactivation in a model of naturally occurring canine non-Hodgkin's lymphoma.
Modiano JF; Breen M; Valli VE; Wojcieszyn JW; Cutter GR
Leukemia; 2007 Jan; 21(1):184-7. PubMed ID: 16990767
[No Abstract] [Full Text] [Related]
35. Prognostic factors in canine mammary tumors: a multivariate study of 202 consecutive cases.
Hellmén E; Bergström R; Holmberg L; Spångberg IB; Hansson K; Lindgren A
Vet Pathol; 1993 Jan; 30(1):20-7. PubMed ID: 8442324
[TBL] [Abstract][Full Text] [Related]
36. Chromosome 14: a breakpoint in non-Hodgkin's lymphomas.
van 't Veer MB
Neth J Med; 1990 Aug; 37(1-2):37-43. PubMed ID: 2215832
[TBL] [Abstract][Full Text] [Related]
37. Spontaneous regression of lymphosarcoma in a dog.
Schwartz SN
J Am Vet Med Assoc; 1988 Jan; 192(2):222-4. PubMed ID: 3350750
[TBL] [Abstract][Full Text] [Related]
38. Nonrandom chromosomal aberrations are associated with sites of tissue involvement in non-Hodgkin's lymphoma.
Offit K; Richardson ME; Ceng QQ; Hampton A; Koduru PR; Jhanwar SC; Filippa DA; Lieberman PH; Clarkson B; Chaganti RS
Cancer Genet Cytogenet; 1989 Jan; 37(1):85-93. PubMed ID: 2917335
[TBL] [Abstract][Full Text] [Related]
39. Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival.
Valli VE; Kass PH; San Myint M; Scott F
Vet Pathol; 2013 Sep; 50(5):738-48. PubMed ID: 23444036
[TBL] [Abstract][Full Text] [Related]
40. The usefulness of cell surface markers in predicting the prognosis of non-Hodgkin's lymphomas.
Baird S
Crit Rev Clin Lab Sci; 1993; 30(1):1-28. PubMed ID: 8489735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
